We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Automated Hematologic Reference Intervals Defined for Newborns

By LabMedica International staff writers
Posted on 05 Jan 2021
Print article
Image: Hematologic Reference Intervals Defined for Newborns on the XN-1000 Automated Hematology Analyzer (Photo courtesy of Sysmex Corporation).
Image: Hematologic Reference Intervals Defined for Newborns on the XN-1000 Automated Hematology Analyzer (Photo courtesy of Sysmex Corporation).
Laboratory tests leverage 60% to 70% of medical decisions and one of the most often ordered and impactful tests is the complete blood count (CBC). These decisions require that clinicians have a standard for interpreting laboratory test results for their patients.

Ethical constraints exist for performing an unnecessary needle stick and collecting non-clinically indicated blood samples from this vulnerable newborn population. Many newborn CBC Reference Intervals (RI) publications have been retrospective and some authors cite this as one of their cardinal limitations.

A team of medical scientists associated with the Banner – University Medical Center Phoenix, (Phoenix, AZ, USA) conducted a prospective study at an academic tertiary care center, and hematology samples were collected from 120 participants deemed to be normal healthy term newborns. Study enrollment occurred between May 24, 2016, and November 1, 2017. A total of 170 blood specimens were sent to the laboratory.

The team used a single Sysmex XN-1000 Automated Hematology Analyzer (Sysmex America, Lincolnshire, IL, USA) to generate a CBC with white blood cell (WBC) differential for each newborn, including the advanced hematology parameters. Distributions were assessed for normality and tested for outliers. Reference intervals were values between the 2.5th percentile and 97.5th percentile.

The scientists reported that the novel reference intervals obtained for this study population are as follows: absolute immature granulocyte count, 80/μL to 1,700/μL; immature granulocyte percentage, 0.6% to 6.1%; reticulocyte hemoglobin equivalent, 31.7 to 38.4 pg; immature reticulocyte fraction, 35.9% to 52.8%; immature platelet count, 4.73 × 103/μL to 19.72 × 103/μL; and immature platelet fraction, 1.7% to 9.8%.

The authors concluded their prospective study has defined hematologic reference intervals for this newborn population, including new advanced clinical parameters from the Sysmex XN-1000 Automated Hematology Analyzer. These reference intervals are proposed as the new standard and can serve as a strong foundation for continued studies to further explore their value in diagnosing and managing morbidities such as sepsis, anemia, and thrombocytopenia. The study was published in the January, 2021 issue of the journal Archives of Pathology and Laboratory Medicine.

Related Links:
Banner – University Medical Center Phoenix
Sysmex America


Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
PSA Test
Human Semen Rapid Test
New
Free Human Prostate-Specific Antigen CLIA
LIAISON fPSA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.